About Patient Analog
The infrastructure layer for human-relevant medicine
Why We Exist
Patient Analog exists to organize the convergence of digital twins, organoids, microphysiological systems, and AI-driven drug discovery into precision medicine's next infrastructure layer.
The FDA Modernization Act 3.0 opened the door. Now we need the framework to walk through it. Human-relevant medicine is not a single technology—it's an ecosystem of complementary approaches that, when integrated, create something greater than the sum of their parts.
Where We're Going
We envision a future where every drug is tested on human-relevant models before entering clinical trials. Where patient-specific digital twins predict individual responses to treatments. Where the cruel inefficiency of animal testing gives way to the precision of human biology.
This isn't just about better science—it's about better medicine. Faster drug development. Fewer failures. More treatments that actually work for the patients who need them.
What We Do
Organize Knowledge
We curate and synthesize information across the human-relevant medicine landscape—technologies, companies, regulations, and research.
Educate
From interactive simulations to comprehensive glossaries, we make complex science accessible to all audiences.
Connect
We provide the conceptual framework that links disparate technologies into a coherent system for human simulation.
Founded By J Radler
Patient Analog was created by J Radler, driven by a deep fascination with the intersection of biotechnology, computational science, and the future of medicine. With a passion for emerging technologies that push the boundaries of what's possible, J Radler envisioned a comprehensive resource that would make the complex world of human-relevant medicine accessible to everyone—from researchers and regulators to curious minds exploring the next frontier of healthcare.
The project emerged from a belief that the future of drug discovery lies not in outdated animal testing paradigms, but in sophisticated human-relevant models that better predict how treatments will work in real patients. From organ-on-chip devices and digital twins to AI-driven drug discovery and personalized organoids, Patient Analog aims to be the central hub where these revolutionary technologies converge.
What started as a personal exploration of biotech's most exciting developments has grown into a comprehensive educational platform. J Radler continues to curate and expand Patient Analog with the same vision that inspired its creation: to accelerate the transition to human-relevant medicine and help build the infrastructure layer for the next era of pharmaceutical innovation.